Leveraging In-Silico Designed Thermogenics to Activate Selective Lipid Degradation Pathways for Sustained Fat Loss

  • Harnessing in-silico molecular design to engineer high-potency thermogenic candidates with superior target specificity, ensuring the activation of fat-burning pathways while avoiding the off-target cardiovascular effects common in historical thermogenic attempts
  • Validating novel lipid-degradation variants through metagenomic adipocyte analysis and in-vitro lipolysis assays, providing a data-driven proof-of-concept for direct adipose tissue reduction independent of caloric intake
  • Optimizing specificity for adipose tissue metabolism to inhibit lipid accumulation at the cellular level, delivering a durable metabolic solution that targets the root cause of obesity-related comorbidities